MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 192 filers reported holding MYRIAD GENETICS INC in Q3 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,695,838 | -30.8% | 2,537,147 | -0.0% | 0.07% | -27.4% |
| Q2 2023 | $58,832,347 | +14.8% | 2,538,065 | +15.0% | 0.10% | +13.1% |
| Q1 2023 | $51,265,311 | +59.3% | 2,206,858 | -0.5% | 0.08% | +47.4% |
| Q4 2022 | $32,188,360 | -36.9% | 2,218,357 | -17.1% | 0.06% | -36.7% |
| Q3 2022 | $51,049,000 | +26.2% | 2,675,545 | +20.2% | 0.09% | +32.4% |
| Q2 2022 | $40,454,000 | -31.0% | 2,226,395 | -4.3% | 0.07% | -11.7% |
| Q1 2022 | $58,645,000 | -1.7% | 2,327,170 | +7.7% | 0.08% | +8.5% |
| Q4 2021 | $59,650,000 | +11.5% | 2,161,219 | +30.4% | 0.07% | +9.2% |
| Q3 2021 | $53,508,000 | +57.1% | 1,657,111 | +48.8% | 0.06% | +58.5% |
| Q2 2021 | $34,054,000 | – | 1,113,599 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |